Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study.
about
Germ cell cancer presenting as gastrointestinal bleeding and developing brain metastases: case report and review of the literature.Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trialEffectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors.Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.Cisplatin resistance in germ cell tumours: models and mechanisms.Testicular choriocarcinoma: a rare variant that requires a unique treatment approach.Emerging Therapeutic Targets for Male Germ Cell Tumors.Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib.Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.Current Management of Refractory Germ Cell Tumors and Future Directions.Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells.Anti-migratory activity of marine alkaloid monanchocidin A - proteomics-based discovery and confirmation.Investigational targeted therapies for the treatment of testicular germ cell tumors.Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization.Platinum-refractory germ cell tumors: an update on current treatment options and developments.Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancerMicro-RNA expression in cisplatin resistant germ cell tumor cell lines.Will Testicular Germ Cell Tumors Remain Untargetable?Exceptional responders: in search of the science behind the miracle cancer cures.Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors.
P2860
Q34475707-5A94A9A3-D2DF-4AE5-8340-8F1032F98A11Q34544846-91C51FFF-8A50-4CDF-8AD8-4AD230221A91Q34928941-3F641108-057C-4926-8EA7-EA862A70B0A9Q37905875-D0BF5237-A510-4577-B4AD-50571BEDBCB0Q38145508-BB39AC95-FA67-4B07-A785-FEBFBFDB9C8FQ38302534-D2DB6BB9-8B76-43F1-98C7-5AD49FFB9C06Q38341798-5BB0A9CE-4D8B-48FD-A0B5-A32A17046108Q38602699-E1E24F16-23E6-44A2-A455-64B20C1F6E65Q38627885-A90F504B-BA1F-4097-B0AE-06281D759214Q38656908-9B69CCD9-B93C-4D07-AD68-93FD79A908E2Q38755132-220E74C3-49EE-48CF-81CF-B9D15B4386BDQ38757753-30CA09D1-8D83-43C3-8C73-FDBA31AB37CFQ38784326-ECD39B51-6C5F-4296-9CBF-B5ECAFC24C9CQ38861307-C747D499-E2AC-4802-9AAB-6CA384CC2BC9Q38861914-2473E6C8-F36C-4324-ADBB-EEFD6F750AA7Q38906007-F9CA82FE-CE85-4E82-BB21-E8B8E6CB6F93Q39241495-4A2D3E9B-CD40-470B-BE75-4E8B9B396CCFQ39541811-25BD8D8F-8FB3-46C2-B2A5-79AC0F6D7F4CQ39762519-7D03FF3D-EC3C-4B25-86C0-4EAD29205858Q48639229-B6CFB9CD-DF3B-401E-A09A-34A3E2052616Q55263819-4E598D94-1EEF-49C4-8EA3-CBEF45BF94EF
P2860
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Preclinical and clinical activ ...... Study Group cooperative study.
@en
Preclinical and clinical activ ...... Study Group cooperative study.
@nl
type
label
Preclinical and clinical activ ...... Study Group cooperative study.
@en
Preclinical and clinical activ ...... Study Group cooperative study.
@nl
prefLabel
Preclinical and clinical activ ...... Study Group cooperative study.
@en
Preclinical and clinical activ ...... Study Group cooperative study.
@nl
P2093
P356
P1433
P1476
Preclinical and clinical activ ...... Study Group cooperative study.
@en
P2093
C Bokemeyer
C Kollmannsberger
E Winquist
F Honecker
J T Hartmann
P Czaykowski
P304
P356
10.1093/ANNONC/MDR026
P577
2011-03-17T00:00:00Z